Teladoc Health Q3 revenue up 17% to $611.4M; net loss narrows to $73.5M

Teladoc Health, Inc.

2022-Q3 EPS reported -$61.09 revenue$1,769,131,000

Q3 revenue $611.4M (+17% YoY); net loss $73.5M ($0.45/sh) vs $84.3M loss prior year.
Adjusted EBITDA $51.2M, above high end of guidance; operating cash flow $63.0M.
Nine-month 2022 net loss $9.85B driven by non-cash goodwill impairment; revenue $1.77B (+20%).
CEO Jason Gorevic cited strong quarter and progress on whole-person care strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.